This is a task order awarded by the U.S. Agency for International Development (USAID) to the prime contractor Domestic Awardees (Undisclosed) under the Famine Early Warning Systems Network (FEWS NET) Indefinite Delivery Contract. The task order, valued at $2,865,965.00, is to provide support for Ebola-affected countries in West Africa, with an effective date of September 10, 2015 and a completion date of June 30, 2017. The contract is cost-plus-fixed-fee with no set-aside designation. Major...
This federal contract award is for the negotiation and award of a one-year contract, with options to extend, for an Ebola Project Management Specialist position under the Health Office. The contract was awarded to Foreign Awardees (Undisclosed), a foreign for-profit organization, by the U.S. Agency for International Development (USAID) Mission in Benin. The contract has a ceiling value of $154,000.00 and is a Definitive Contract using a Labor Hours pricing type. The contract is part of USAID's...
This is a $504,517 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Duke University for services related to the RFTOP 2015-009 AR EBOLA requirement. The order is issued under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) indefinite delivery, indefinite quantity (IDIQ) contract. The work will be performed in Durham, North Carolina, and the period of performance runs through December 31, 2017. No...
This is a $62,511,942.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to Mapp Biopharmaceutical, Inc., a biotechnology company based in San Diego, California. The contract is for the development of an anti-Sudan ebolavirus medical countermeasure, a critical public health and national security priority. Mapp Biopharmaceutical has a strong...
This federal contract award from the Centers for Disease Control and Prevention (CDC) to General Dynamics Information Technology, Inc. (GDIT), a division of CSRA LLC, is for EBOLA SURGE SUPPORT services. The $490,635.96 Time and Materials contract is a Blanket Purchase Agreement (BPA) Call under the Mission Oriented Business Integrated Services (MOBIS) Federal Supply Schedule. It does not have a set-aside designation. GDIT, as a major IT services provider to various federal agencies, will...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $91,350 firm fixed price delivery order contract to Cepheid, a subsidiary of Danaher Corporation, for EBOLA ASSAY KITS. The contract will provide assay kits to test for the Ebola virus and supports the agency's chemical and biological defense programs. Performance will occur in Atlanta, Georgia over a three month period concluding in May 2022. No subcontractors or set aside designations were...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subcomponent of the U.S. Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of a human anti-Zaire Ebola virus glycoprotein (GP) IgG ELISA kit and low NSB diluent bottle. The contract has a ceiling value of $82,765.00 and a performance period ending on May 1,...
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Health Core, Inc. The contract was awarded under the Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) IDIQ contract vehicle. The award is for $1,339,667.27 on a firm fixed price basis and has an ultimate completion date of August 2, 2018. The contract supports the CDC's response to the 2015 Ebola outbreak, but does not have a set-aside designation. Health Core, Inc. is the...
This contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $43,075,091.00 cost-plus-fixed-fee contract provides research, development, and production services to support studies and operations related to the Ebola virus and other emerging and re-emerging infectious diseases. Leidos Biomedical Research has served as a prime contractor and...